What were IOL Chemicals & Pharmaceuticals Ltd's latest quarterly results?
IOL Chemicals & Pharmaceuticals Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: 0.0%
- Revenue Growth YoY: +10.9%
- Operating Margin: 10.0%
IOL Chemicals & Pharmaceuticals Ltd: Stock Analysis & Fundamentals
Updated this weekIOL Chemicals & Pharmaceuticals Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 18.4. ROE: 6.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
📊Debt increased 36% YoY — leverage rising
👔Promoter buying — stake up 4.4% this quarter
🌐FII stake increased 0.6% this quarter
Key Numbers
Current Price
₹78
Dividend Yield
1.28%
Market Cap
2.3K Cr
Valuation
N/AOther Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: IOL Chemicals & Pharmaceuticals Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is IOL Chemicals & Pharmaceuticals Ltd's current PE ratio?
IOL Chemicals & Pharmaceuticals Ltd's current PE ratio is 18.4x.
- Current PE: 18.4x
- Market Cap: 2.3K Cr
- Dividend Yield: 1.28%
What is IOL Chemicals & Pharmaceuticals Ltd's price-to-book ratio?
IOL Chemicals & Pharmaceuticals Ltd's price-to-book ratio is 1.3x.
- Price-to-Book (P/B): 1.3x
- Book Value per Share: ₹60
- Current Price: ₹78
Is IOL Chemicals & Pharmaceuticals Ltd a fundamentally strong company?
IOL Chemicals & Pharmaceuticals Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 9.0%
Is IOL Chemicals & Pharmaceuticals Ltd debt free?
IOL Chemicals & Pharmaceuticals Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹159 Cr
What is IOL Chemicals & Pharmaceuticals Ltd's return on equity (ROE) and ROCE?
IOL Chemicals & Pharmaceuticals Ltd's return ratios over recent years
- FY2023: ROCE 14.0%
- FY2024: ROCE 12.0%
- FY2025: ROCE 9.0%
Is IOL Chemicals & Pharmaceuticals Ltd's cash flow positive?
IOL Chemicals & Pharmaceuticals Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹179 Cr
- Free Cash Flow (FCF): ₹25 Cr
- CFO/PAT Ratio: 177% (strong cash conversion)
What is IOL Chemicals & Pharmaceuticals Ltd's dividend yield?
IOL Chemicals & Pharmaceuticals Ltd's current dividend yield is 1.28%.
- Dividend Yield: 1.28%
- Current Price: ₹78
Who holds IOL Chemicals & Pharmaceuticals Ltd shares — promoters, FII, DII?
IOL Chemicals & Pharmaceuticals Ltd's shareholding pattern (Dec 2025)
- Promoters: 52.6%
- FII (Foreign): 2.1%
- DII (Domestic): 0.0%
- Public: 45.3%
Is promoter holding increasing or decreasing in IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 52.6% (Dec 2025)
- Previous Quarter: 52.6% (Sep 2025)
- Change: 0.00% (stable)
Is IOL Chemicals & Pharmaceuticals Ltd a new momentum entry or an established outperformer?
IOL Chemicals & Pharmaceuticals Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is IOL Chemicals & Pharmaceuticals Ltd worth studying for long term investment?
Based on quantitative research signals, here is why IOL Chemicals & Pharmaceuticals Ltd may be worth studying
- Cash flow is positive — CFO ₹179 Cr
What is the investment thesis for IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd investment thesis summary:
What is the future outlook for IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.